1 2 3 4 5 6 7 8 9 10 11 12 13 14
далее 0; 55(4): 501-505 21. Haitel A, Wiener HG, Blaschitz U et al. Biologic behavior and p53 overexpression in multifocal renal cell carcinoma of clear cell type: an immunohistochemical study correlating grading, staging, and proliferation markers. Cancer 1999; 85 (4):432-438 22. Chemeris G, Loktinov A, Rempel A et al. Elevated content of p53 protein in the absence of p53 gene mutations as a possible prognostic marker for human renal cell tumors. Virchows Arch 1995; 426 (б): 563-569 23. Ghanem MA, Van der Kwast TH, Den Hollander JC et al. The prognostic significance of apoptosis-associated proteins BCL-2, BAX and BCL-X in clinical nephroblastoma. J Cancer 2001 ;85( 10): 1557-1563 24. Paraf F, Gogusev J, Chretien Y, Droz D. Expression of bcl-2 oncoprotein in renal cell tumours. J Pathol 1995; 177 (З): 247-252 25. Chandler D, el-Naggar AK, Brisbay S et al. Apoptosis and expression of the bcl-2 proto-oncogene in the fetal and adult human kidney: evidence for the contribution of bcl-2 expression to renal carcinogenesis. Hum Pathol 1994; 25 (8): 789-796 26. Velickovic M, Delahunt В, Mclver В, Grebe SK. Intragenic PTEN/MMACI loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis. Mod Pathol 200; 15 (5): 479-485 27. Brenner W, Farber G, Herget Т et al. Loss of tumor suppressor protein PTEN during renal carcinogenesis. Int J Cancer 2002 May; 99 (1): 53-57 28. Haitel A, Wiener HG, Neudert В et al. Expression of the cell cycle proteins p21, p27, and pRb in clear cell renal cell carcinoma and their prognostic significance. Urology 2001; 58 (З):477-481 29. Yokogi H. Flow cytometric quantitation of the proliferationassociated nuclear antigen p105 and DNA content in patients with renal cell carcinoma. Cancer 1996;78 (4): 819-826 30. Leroy X, Zerimech F, Zini L et al. MUC1 expression is correlated with nuclear grade and tumor progression in pT1 renal clear cell carcinoma. Am J Clin Pathol 2002; 118(1): 47-51 31. Kraus S, Abel PD, Nachtmann С et al. MUC1 mucin and trefoil factor 1 protein expression in renal cell carcinoma: correlation with prognosis. Hum Pathol 2002; 33 (1): 60-67 32. Fujita K, Denda К, Yamamoto M et al. Expression of MUC1 mucins inversely correlated with post-surgical survival of renal cell carcinoma patients. Br J Cancer 1999;80 (1-2); 301-308 33. Rotter M, Block T, Busch R et al. Expression of HER-2/ neu in renal-cell carcinoma. Correlation with histologic subtypes and differentiation. J Cancer 1992; 52 (2): 213-217 34. Fontana LO, Garcia Garcia F, Areas Martinez Salas I et al. The expression of p53 and c-erb-2 in transitional cell carcinoma of the kidney pelvis and ureter and its relation to tumor progression and survival. Arch Esp Urol 2002; 55(7): 792796 35. Ramp U, Bretschneider U, Ebert T et al. Prognostic implications of CD95 receptor expression in clear cell renal carcinomas. Hum Pathol 2003; 34 (2): 174-179 36. Rasmuson T, Grankvist К, Jacobsen J, Ljungberg В. Impact of serum bas далее ...